Chapter 5.7 Enhancing resilience to stress: the role of signaling cascades

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 1, 2005, Pages 751-771

  Yuan, Pei Xiong ^a   Zhou, Rulun ^a   Farzad, Neda ^a   Gould, Todd D ^a   Gray, Neil A ^a   Du, Jing ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956693124     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80040-9     Document Type: Chapter

References (143)

1. Atkins C.M., Selcher J.C., Petraitis J.J., Trzaskos J.M., and Sweatt J.D. The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1 (1998) 602-609
2. Bijur G.N., De Sarno P., and Jope R.S. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 275 (2000) 7583-7590
3. Blum S., Moore A.N., Adams F., and Dash P.K. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J. Neurosci. 19 (1999) 3535-3544
4. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., and Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286 (1999) 1358-1362
5. Bremner J.D., Randall P., Scott T.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiatry 152 (1995) 973-981
6. Bremner J.D., Randall P., Vermetten E., et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol. Psychiatry 41 (1997) 23-32
7. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
8. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
9. Bruno V., Sortino M.A., Scapagnini U., Nicoletti F., and Canonico P.L. Antidegenerative effects of Mg(2+)-valproate in cultured cerebellar neurons. Funct. Neurol. 10 (1995) 121-130
10. Brunson K.L., Eghbal-Ahmadi M., Bender R., Chen Y., and Baram T.Z. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc. Natl. Acad. Sci. USA 98 (2001) 8856-8861
11. Cameron H.A., and McKay R.D. Restoring production of hippocampal neurons in old age. Nat. Neurosci. 2 (1999) 894-897
12. Charney D.S., and Bremner J.D. The neurobiology of anxiety disorders. In: Bunney B.S. (Ed). Neurobiology of Mental Illness (1999), Oxford University Press, San Diego 494-517
13. Chemerinski E., and Robinson R.G. The neuropsychiatry of stroke. Psychosomatics 41 (2000) 5-14
14. Chen A.C., Shriayama Y., Shin K.H., Neve R.L., and Duman R.S. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol. Psychiatry 49 (2001) 753-762
15. Chen D.F., and Tonegawa S. Why do mature CNS neurons of mammals fail to re-establish connections following injury - functions of bcl-2. Cell Death Differ. 5 (1998) 816-822
16. Chen D.F., Schneider G.E., Martinou J.C., and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385 (1997) 434-439
17. Chen G., Zeng W.Z., Yuan P.X., et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72 (1999) 879-882
18. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., and Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75 (2000) 1729-1734
19. (3 Pt 2). Chen G., Masana M.I., and Manji H.K. Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Review. Bipolar Disorder 2000 Sep 2 (2000) 217-236
20. Chen R.W., and Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J. Biol. Chem. 274 (1999) 6039-6042
21. Chierzi S., Strettoi E., Cenni M.C., and Maffei L. Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J. Neurosci. 19 (1999) 8367-8376
22. Chuang D.M., Chen R., Chalecka-Franaszek E., et al. Neuroprotective effects of lithium in cultured cells and animal model of diseases. Bipolar Disorders 4 (2002) 129-136
23. Crow T., Xue-Bian J.J., Siddiqi V., Kang Y., and Neary J.T. Phosphorylation of mitogen-activated protein kinase by one-trial and multi-trial classical conditioning. J. Neurosci. 18 (1998) 3480-3487
24. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell - intrinsic death machinery. Cell 91 (1997) 231-241
25. DeVries A.C., Joh H.D., Bernard O., et al. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc. Natl. Acad. Sci. USA 98 (2001) 11824-11828
26. Dijkers P.F., Medema R.H., Lammers J.W., Koenderman L., and Coffer P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10 (2000) 1201-1204
27. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
28. Drevets W.C., Price J.L., Simpson Jr. J.R., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
29. Drevets W.C., Gadde K., and Krishnan R. Neuroimaging studies of depression. In: Bunney B.S. (Ed). Neurobiology of Mental Illness (1999), Oxford University Press, New York 394-418
30. D'Sa C., and Duman R. Antidepressants and neuroplasticity. Bipolar Disorder 4 (2002) 183
31. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol. Psychiatry 44 (1998) 324-335
32. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46 (1999) 1181-1191
33. Duman R.S., Malberg J., Nakagawa S., and D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48 (2000) 732-739
34. English J.D., and Sweatt J.D. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 271 (1996) 24329-24332
35. English J.D., and Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272 (1997) 19103-19106
36. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., et al. Neurogenesis in the adult human hippocampus. Nat. Med. 4 (1998) 1313-1317
37. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron 25 (2000) 11-14
38. Francis D., Diorio J., Liu D., and Meaney M.J. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286 (1999) 1155-1158
39. Fryer R.H., Kaplan D.R., Feinstein S.C., Radeke M.J., Grayson D.R., and Kromer L.F. Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J. Comp. Neurol. 374 (1996) 21-40
40. Fukunaga K., and Miyamoto E. Role of MAP kinase in neurons. Mol. Neurobiol. 16 (1998) 79-95
41. Gass P., Kretz O., Wolfer D.P., et al. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep. 1 (2000) 447-451
42. Geiman T.M., and Robertson K.D. Chromatin remodeling, histone modifications, and DNA methylation - how does it all fit together?. J. Cell. Biochem. 87 (2002) 117-125
43. Gesing A., Bilang-Bleuel A., Droste S.K., Linthorst A.C., Holsboer F., and Reul J.M. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J. Neurosci. 21 (2001) 4822-4829
44. Gilbertson M.W., Shenton M.E., Ciszewski A., et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 5 (2002) 1242-1247
45. Gonzalez M., Ruggiero F.P., Chang Q., et al. Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 24 (1999) 567-583
46. Gottesman I.I., Shields J., and Hanson D.R. Schizophrenia, the epigenetic puzzle (1982), Cambridge University Press, New York, NY
47. Gould E., Tanapat P., Rydel T., and Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry 48 (2000) 715-720
48. Gould T., Chen G., and Manji H. Mood stabilizer psychopharmacology. Clinical Neuroscience Research 2 (2002) 193-212
49. Gould T., Du J., Yuan P., Chen G., and Manji H. Evidence suggesting activation of the Wnt signaling pathway in rat brain after lithium and valproic acid administration. Biol. Psychiatry 51 (2002) 39S
50. Gould T.D., and Manji H.K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 8 (2002)
51. Graham Y.P., Heim C., Goodman S.H., Miller A.H., and Nemeroff C.B. The effects of neonatal stress on brain development: implications for psychopathology. Dev. Psychopathol. 11 (1999) 545-565
52. Gurvits T.V., Shenton M.E., Hokama H., et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol. Psychiatry 40 (1996) 1091-1099
53. Hashimoto R., Hough C., Nakazawa T., Yamamoto T., and Chuang D.M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 80 (2002) 589-597
54. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 (2001) 1023-1039
55. Hetman M., Cavanaugh J.E., Kimelman D., and Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20 (2000) 2567-2574
56. Holm K.H., Cicchetti F., Bjorklund L., et al. Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum. Neuroscience 104 (2001) 397-405
57. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
58. Jacobs B.L., Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 5 (2000) 262-269
59. Kempermann G. Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression. Bipolar Disord. 4 (2002) 17-33
60. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 (1997) 493-495
61. Kollack-Walker S., Day H.E.W., and Akil H. Central stress neurocircuits. In: Fink G. (Ed). Encyclopedia of Stress (2000), Academic Press, Cambridge, New York
62. Kornhauser J.M., and Greenberg M.E. A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron 18 (1997) 839-842
63. Korte S.M., De Kloet E.R., Buwalda B., Bouman S.D., and Bohus B. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur. J. Pharmacol. 301 (1996) 19-25
64. Kumar A., Miller D., Ewbank D., et al. Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am. J. Geriatr. Psychiatry 5 (1997) 15-25
65. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., and Plotsky P.M. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 122 (2000) 81-103
66. Lenox R.H., Gould T.D., and Manji H.K. Endophenotype in bipolar disorder. Am. J. Med. Genet. 114 (2002) 391-406
67. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 43 (1998) 547-573
68. Lyons D.M. Stress, depression, and inherited variation in primate hippocampal and prefrontal brain development. Psychopharmacology Bulletin 36 (2002) 27-43
69. Lyons D.M., Yang C., Sawyer-Glover A.M., Moseley M.E., and Schatzberg A.F. Early life stress and inherited variation in monkey hippocampal volumes. Arch. Gen. Psychiatry 58 (2001) 1145-1151
70. Maggirwar S.B., Sarmiere P.D., Dewhurst S., and Freeman R.S. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J. Neurosci. 18 (1998) 10356-10365
71. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 (1995) 7929-7939
72. Manev H., Uz T., Smalheiser N.R., and Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 411 (2001) 67-70
73. Manji H.K., and Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol. Psychiatry 7 Suppl. 1 (2002) 46-56
74. Manji H., and Duman R. Impairments of neuroplasticity and cellular resilience in severe mood disorder: implications for the development of novel therapeutics. Psychopharmacology Bulletin 35 (2001) 5-49
75. Manji H.K., Moore G.J., and Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?. Biol. Psychiatry 46 (1999) 929-940
76. Manji H.K., Moore G.J., and Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry 48 (2000) 740-754
77. Manji H.K., Moore G.J., Rajkowska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry 5 (2000) 578-593
78. Manji H.K., Moore G.J., and Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61 (2000) 82-96
79. Manji H.K., Moore G.J., and Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry 178 (2001) 10707-10719
80. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
81. Manji H.K., Moore G.J., and Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry Suppl 41 (2001) 10707-10719
82. Mark R.J., Ashford J.W., Goodman Y., and Mattson M.P. Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging 16 (1995) 187-198
83. Martin K.C., Michael D., Rose J.C., et al. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18 (1997) 899-912
84. Matsubara M., Kusubata M., Ishiguro K., Uchida T., Titani K., and Taniguchi H. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J. Biol. Chem. 271 (1996) 21108-21113
85. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22 (1999) 105-122
86. McQuade R., and Young A.H. Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br. J. Psychiatry 177 (2000) 390-395
87. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24 (2001) 1161-1192
88. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24 (1999) 521-529
89. Michaloudi H.C., el Majdoubi M., Poulain D.A., Papadopoulos G.C., and Theodosis D.T. The noradrenergic innervation of identified hypothalamic magnocellular somata and its contribution to lactation-induced synaptic plasticity. J. Neuroendocrinol. 9 (1997) 17-23
90. Moore G.J., Bebchuk J.M., Hasanat K., et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol. Psychiatry 48 (2000) 1-8
91. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K., and Menji H.K. Lithium-induced increase in human brain grey matter. Lancet 356 (2000) 1241-1242
92. Murphy T.H., Blatter L.A., Bhat R.V., Fiore R.S., Wier W.G., and Baraban J.M. Differential regulation of calcium/calmodulin-dependent protein kinase II and p42 MAP kinase activity by synaptic transmission. J. Neurosci. 14 (1994) 1320-1331
93. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997) 1436-1442
94. Nestler E.J. Antidepressant treatments in the 21st century. Biol. Psychiatry 44 (1998) 526-533
95. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
96. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
97. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
98. Nibuya M., Takahashi M., Russell D.S., and Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci. Lett. 267 (1999) 81-84
99. Oh Y.J., Swarzenski B.C., and O'Malley K.L. Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth. Neurosci. Lett. 202 (1996) 161-164
100. Ontiveros A., Fontaine R., Breton G., Elie R., Fontaine S., and Dery R. Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging. J. Neuropsychiatry Clin. Neurosci. 1 (1989) 404-408
101. Patapoutian A., and Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11 (2001) 272-280
102. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., and Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiatry. Res. 34 (2000) 383-392
103. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet. 17 (2001) 142-146
104. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2 (2001) 24-32
105. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48 (2000) 766-777
106. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 4 (2002) 105-116
107. Reul J.M., and Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2 (2002) 23-33
108. Riccio A., Pierchala B.A., Ciarallo C.L., and Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 277 (1997) 1097-1100
109. Riccio A., Ahn S., Davenport C.M., Blendy J.A., and Ginty D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286 (1999) 2358-2361
110. Roberson E.D., English J.D., and Sweatt J.D. A biochemist's view of long-term potentiation. Learn Mem. 3 (1996) 1-24
111. Roberson E.D., English J.D., Adams J.P., Selcher J.C., Kondratick C., and Sweatt J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J. Neurosci. 19 (1999) 4337-4348
112. Robinson M.J., Stippec S.A., Goldsmith E., White M.A., and Cobb M.H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8 (1998) 1141-1150
113. Sanchez M.M., Young L.J., Plotsky P.M., and Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 20 (2000) 4657-4668
114. Sanchez M.M., Ladd C.O., and Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 13 (2001) 419-449
115. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1 (1996) 1-19
116. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57 (2000) 925-935
117. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol. Psychiatry 48 (2000) 755-765
118. Selye H. The Stress of Life (1956), McGraw-Hill, San Diego
119. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
120. Simmons N.E., Alden T.D., Thorner M.O., and Laws Jr. E.R. Serum cortisol response to transsphenoidal surgery for Cushing disease. J. Neurosurg. 95 (2001) 1-8
121. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56 (1997) 131-137
122. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15 (1995) 1768-1777
123. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., and Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97 (2000) 253-266
124. Starkman M.N., Giordani B., Gebarski S.S., Berent S., Schork M.A., and Schteingart D.E. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 46 (1999) 1595-1602
125. Steckler T., Rammes G., Sauvage M., van Gaalen M.M., Weis C., Zieglgansberger W., and Holsboer F. Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. J. Psychiat. Res. 35 1 (2001) 29-42
126. Steffens D.C., and Krishnan K.R. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol. Psychiatry 43 (1998) 705-712
127. Steffens D.C., Helms M.J., Krishnan K.R., and Burke G.L. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 30 (1999) 2159-2166
128. Stein M.B., Koverola C., Hanna C., Torchia M.G., and McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 27 (1997) 951-959
129. Stern J.E., and Armstrong W.E. Reorganization of the dendritic trees of oxytocin and vasopressin neurons of the rat supraoptic nucleus during lactation. J. Neurosci. 18 (1998) 841-853
130. Suzuki T., Okumura-Noji K., and Nishida E. ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in postsynaptic density fractions from the rat brain. Neurosci. Res. 22 (1995) 277-285
131. Thome J., Sakai N., Shin K., et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20 (2000) 4030-4036
132. Trentani A., Kuipers S.D., Ter Horst G.J., and Den Boer J.A. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology?. Eur. J. Neurosci. 15 10 (2002) 1681-1691
133. van Praag H., Kempermann G., and Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 2 (1999) 266-270
134. Weaver I.C., La Plante P., Weaver S., et al. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Mol. Cell. Endocrinol. 185 (2001) 205-218
135. Abstract Soc. Weaver I.C.G., Cervoni N., Szyf M., and Meaney M.J. Maternal behavior in infancy regulates methylation of hippocampal glucocorticoid receptor promoter. Vol. abstract number 866.9. Neuroscience Annual Meeting (2002)
136. Webster O., Orthmann, et al. Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia. Schizophrenia Research 41 (1999) 111
137. Wellman C.L. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J. Neurobiol. 49 (2001) 245-253
138. Withers G.S., and Greenough W.T. Reach training selectively alters dendritic branching in subpopulations of layer II-III pyramids in rat motor-somatosensory forelimb cortex. Neuropsychologia 27 (1989) 61-69
139. 2001. Woodgett J.R. Judging a protein by more than its name: gsk-3. Sci STKE (2001) RE12
140. Xu Q., Fawcett T.W., Gorospe M., Guyton K.Z., Liu Y., and Holbrook N.J. Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hypertension 30 (1997) 106-111
141. Young L.T. Neuroprotective effects of antidepressant and mood stabilizing drugs. J. Psychiatry Neurosci. 27 (2002) 8-9
142. Yuan D., Komatsu K., Tani H., Cui Z., and Kano Y. Pharmacological properties of traditional medicines. XXIV. Classification of antiasthmatics based on constitutional predispositions. Biol. Pharm. Bull. 21 (1998) 1169-1173
143. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., and Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276 (2001) 31674-31683